Tri-Lo-Sprintec (norgestimate and ethinyl estradiol) tablets USP - triphasic regimen, packaged in carton containing 3 Blister Cards, 28 Tablets Each, Rx only, Teva Pharmaceuticals USA, INC, North Wales, PA 19454, NDC 0093-2140-62
Published April 3, 2024 · Recall initiated: March 7, 2024
Summary
FDA records drug Class II recall D-0428-2024, published April 3, 2024 and initiated March 7, 2024. Recalling firm: Teva Pharmaceuticals USA, Inc; Status: Terminated; Reported quantity: 92,676 cartons; Lot: Lot # 100039678, Exp 04/31/2024; 100038111, 100042277, Exp 07/31/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications
What to do
Voluntary: Firm initiated · Letter
Get an email if TRI-LO-SPRINTEC has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- TRI-LO-SPRINTEC
- Manufacturer
- Teva Pharmaceuticals USA, Inc
- Distributor
- USA nationwide.
- Lot
- Lot # 100039678, Exp 04/31/2024; 100038111, 100042277, Exp 07/31/2024
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAVCF Vaginal Contraceptive Film (nonoxynol-9, 28%), package in a carton with 9 single films, Distributed By:April 3, 2024
- FDATreprostinil Injection, 20 mg/20 mL (1 mg/mL), For Subcutaneous or Intravenous Infusion Only, 20 mLApril 3, 2024
- FDADivalproex Sodium Extended-release Tablets, USP 250 mg, Rx Only, 100 tablets, Manufactured by: AmnealApril 3, 2024
- FDAHimalayan Pain Relief Tea for Gout and HangoverApril 3, 2024
- FDAVANCOMYCIN 1.25 g added to 0.9% Sodium Chloride 250 mL Injection, 250 mL bag, Rx only, SCA Pharmaceuticals,April 3, 2024
- FDAThe label reads, "Golden Sunrise Cold Pressured Juice Carrot, Orange, Pineapple, Lemon, Ginger & Turmeric 11April 3, 2024
Questions about this recall
Was Tri-Lo-Sprintec (norgestimate and ethinyl estradiol) tablets USP - triphasic regimen, packaged in carton containing 3 Blister Cards, 28 Tablets Each, Rx only, Teva Pharmaceuticals USA, INC, North Wales, PA 19454, NDC 0093-2140-62 recalled?
Yes. FDA published recall D-0428-2024 on April 3, 2024. Reported hazard: Failed Dissolution Specifications
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: TRI-LO-SPRINTEC.